These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9972842)

  • 61. Individual responses to novelty predict qualitative differences in d-amphetamine-induced open field but not reward-related behaviors in rats.
    Antoniou K; Papathanasiou G; Panagis G; Nomikos GG; Hyphantis T; Papadopoulou-Daifoti Z
    Neuroscience; 2004; 123(3):613-23. PubMed ID: 14706774
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of repeated exposure to toluene or amphetamine on locomotor activity in rats.
    Wiaderna D; Tomas T
    Int J Occup Med Environ Health; 2000; 13(4):317-24. PubMed ID: 11276845
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mifepristone prevents the expression of long-term behavioural sensitization to amphetamine.
    De Vries TJ; Schoffelmeer AN; Tjon GH; Nestby P; Mulder AH; Vanderschuren LJ
    Eur J Pharmacol; 1996 Jun; 307(2):R3-4. PubMed ID: 8832229
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fixed-ratio discrimination training as replacement therapy in Parkinson's disease: studies in a 6-hydroxydopamine-treated rat model.
    Van Keuren KR; Stodgell CJ; Schroeder SR; Tessel RE
    Brain Res; 1998 Jan; 780(1):56-66. PubMed ID: 9473587
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sensitization of the locomotor response to psychostimulants after repeated opiate exposure: role of the nucleus accumbens.
    Cunningham ST; Finn M; Kelley AE
    Neuropsychopharmacology; 1997 Feb; 16(2):147-55. PubMed ID: 9015797
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The CCK-system mediates adaptation to novelty-induced stress in the rat: a pharmacological evidence.
    Ballaz SJ; Akil H; Watson SJ
    Neurosci Lett; 2007 Nov; 428(1):27-32. PubMed ID: 17950531
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of 5-HT1B receptor ligands microinjected into the ventral tegmental area on the locomotor and sensitizating effects of cocaine in rats.
    Przegaliński E; Papla I; Siwanowicz J; Filip M
    Eur Neuropsychopharmacol; 2004 May; 14(3):217-25. PubMed ID: 15056481
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Rat locomotion and release of acetylcholinesterase.
    Heiland B; Greenfield SA
    Pharmacol Biochem Behav; 1999 Jan; 62(1):81-7. PubMed ID: 9972849
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Susceptibility to amphetamine-induced locomotor sensitization is modulated by environmental stimuli.
    Fraioli S; Crombag HS; Badiani A; Robinson TE
    Neuropsychopharmacology; 1999 Jun; 20(6):533-41. PubMed ID: 10327423
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stressor- or drug-induced sensitization of the corticosterone response is not critically involved in the long-term expression of behavioural sensitization to amphetamine.
    Schmidt ED; Tilders FJ; Binnekade R; Schoffelmeer AN; De Vries TJ
    Neuroscience; 1999; 92(1):343-52. PubMed ID: 10392855
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diazepam blocks 50 kHz ultrasonic vocalizations and stereotypies but not the increase in locomotor activity induced in rats by amphetamine.
    de Oliveira Guaita G; Vecchia DD; Andreatini R; Robinson DL; Schwarting RKW; Da Cunha C
    Psychopharmacology (Berl); 2018 Jul; 235(7):1887-1896. PubMed ID: 29572651
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice.
    Mcgeehan AJ; Janak PH; Olive MF
    Psychopharmacology (Berl); 2004 Jul; 174(2):266-73. PubMed ID: 14726993
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Amphetamine-induced rapid-onset sensitization: role of novelty, conditioning and behavioral parameters.
    Alvarez Jdo N; Fukushiro DF; Tatsu JA; de Carvalho EP; Gandolfi AC; Tsuchiya JB; Carrara-Nascimento PF; Lima ML; Bellot RG; Frussa-Filho R
    Pharmacol Biochem Behav; 2006 Apr; 83(4):500-7. PubMed ID: 16630649
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Analysis of the long-lasting antagonistic effect of caerulein on amphetamine hyperactivity in rats.
    Matsubara K; Matsushita A
    Jpn J Pharmacol; 1985 Aug; 38(4):381-90. PubMed ID: 4068379
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neural circuit mechanisms of the cholecystokinin (CCK) neuropeptide system in addiction.
    Ma Y; Giardino WJ
    Addict Neurosci; 2022 Sep; 3():. PubMed ID: 35983578
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Repeated administration of methamphetamine blocked cholecystokinin-octapeptide injection-induced c-fos mRNA expression without change in capsaicin-induced junD mRNA expression in rat cerebellum.
    Hamamura M; Ozawa H; Ozaki M; Shimazoe T; Terada Y; Fukumaki Y
    J Neural Transm (Vienna); 2010 Sep; 117(9):1041-53. PubMed ID: 20680358
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cholecystokinin receptor subtypes: role in the modulation of anxiety-related and reward-related behaviours in animal models.
    Rotzinger S; Vaccarino FJ
    J Psychiatry Neurosci; 2003 May; 28(3):171-81. PubMed ID: 12790157
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The expression of behavioral sensitization to amphetamine: role of CCK(A) receptors.
    DeSousa NJ; Wunderlich GR; De Cabo C; Vaccarino FJ
    Pharmacol Biochem Behav; 1999 Jan; 62(1):31-7. PubMed ID: 9972842
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cholecystokinin modulates both the development and the expression of behavioral sensitization to amphetamine in the rat.
    Wunderlich GR; DeSousa NJ; Vaccarino FJ
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):283-90. PubMed ID: 10972475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.